NRTIs (nucleoside reverse transcriptase inhibitors) inhibit mitochondrial DNA polymerase gamma in addition to viral reverse transcriptase. This causes mitochondrial toxicity — directly depleting CoQ10 and impairing the electron transport chain. This is the mechanism behind NRTI-induced lipodystrophy, peripheral neuropathy, and lactic acidosis.
Haugaard et al. (JAIDS, 2004) — CoQ10 significantly reduced in HIV patients on NRTI regimens. De la Asuncion et al. (J Clin Invest, 1998) — NRTI-induced oxidative mtDNA damage reversed by CoQ10 + Vitamin E in animal models.
Peripheral neuropathy, fatigue, lipodystrophy, lactic acidosis risk, muscle wasting
Ubiquinol 200–400mg daily. This is critical in NRTI regimens — not optional. Use with fat-containing meal.
View on Fullscript: Life Extension Super Ubiquinol CoQ10Discuss with your physician before adjusting supplementation. This is educational content, not medical advice.
NRTIs impair carnitine biosynthesis and transport. Carnitine is required to shuttle long-chain fatty acids into mitochondria for oxidation. NRTI-induced carnitine deficiency directly causes peripheral neuropathy and myopathy — two of the most disabling side effects.
De Simone et al. (AIDS, 1992) — carnitine deficiency documented in HIV/AIDS patients. Famularo et al. (AIDS, 1994) — L-carnitine supplementation reversed peripheral neuropathy in NRTI patients in RCT.
Peripheral neuropathy (painful), myopathy, cardiac dysfunction, fatigue, cognitive impairment
L-Carnitine or Acetyl-L-Carnitine 1,000–2,000mg daily. Acetyl-L-carnitine preferred for neuropathy (crosses blood-brain barrier). Discuss with HIV specialist.
View on Fullscript: Jarrow ALCAR (Acetyl-L-Carnitine) 500mgDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
HIV infection itself, reduced sun exposure (common in illness), tenofovir-based regimens (renal tubular effects), and antiretroviral-induced bone loss all converge on Vitamin D deficiency. Tenofovir (Viread/Truvada) specifically causes renal phosphate wasting and bone demineralization.
Brown & Bertran (Clin Infect Dis, 2008) — 75% of HIV patients are Vitamin D deficient. Tenofovir-associated Fanconi syndrome and bone loss documented extensively. DHHS Guidelines recommend D3 supplementation in all HIV patients.
Bone loss, osteoporosis, muscle weakness, immune suppression (compounding HIV-related immune deficit)
Vitamin D3 2,000–4,000 IU + K2 daily. Test quarterly — D3 deficiency correction improves immune function in HIV. Particularly critical with tenofovir-based regimens.
View on Fullscript: Thorne Vitamin D/K2 LiquidDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Taking HIV Antiretrovirals? Build Your Replenishment Stack.
Our clinical intake tool accounts for your medications, health goals, and risk factors — and outputs a personalized supplement protocol rated against published clinical trials.
Open the Full Tool Suite